A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine

J Clin Pharmacol. 1990 Feb;30(2):174-80. doi: 10.1002/j.1552-4604.1990.tb03459.x.
No abstract available

MeSH terms

  • Bayes Theorem*
  • Humans
  • Odds Ratio
  • Polyradiculoneuropathy / chemically induced*
  • Polyradiculoneuropathy / epidemiology
  • Probability*
  • Time Factors
  • Zimeldine / adverse effects*

Substances

  • Zimeldine